{{ (moduleVm.actions && moduleVm.changeStatus) ? moduleVm.status : '' }} CRNI® Recertification Units & CE Credit - Infusion Topics: Buffered Lidocaine; Fist Clenching and Vein Visibility; Removing Heparin From IVADs; TAAEs

Activity Steps

Description

By participating in this activity you will earn CRNI Recertification and CE Credit.

This issue contains the following articles:
  • Changing the Buffer in Buffered Lidocaine
  • Effect of Fist Clenching on Vein Visibility and Palpability
  • Implementation of an Evidence-Based Practice Change Removing Heparin From Implanted Venous Access Devices
  • Transfusion-Associated Adverse Events

Learning Objectives

After completing this continuing education activity you will be able to:

  1. Identify the cause of the pain and discomfort that may be experienced with the injection of unbuffered lido- caine.
  2. Compare the effects from the injection of lidocaine buffered with saline to the effects of the injection of lidocaine buffered with bicarbonate.
  3. Compare the cost of using lidocaine buffered with saline to lidocaine buffered with bicarbonate for local injection prior to inserting a peripherally inserted central cathe- ter (PICC).
  4. Explain the proper ratios for mixing a 1:10 solution of lidocaine buffered with saline.
  5. Identify the maximum recommended tourniquet time for peripheral intravenous catheter (PIVC) insertion.
  6. Analyze results from a study examining the average number and duration of fist clenching to increase vein visibility and palpability before PIVC insertion.
  7. Identify features of a practice using 0.9% sodium chloride for flushing and locking implanted venous access devices (IVADs).
  8. Compare results of flushing and locking IVADs with 0.9% sodium chloride plus heparin versus 0.9% sodi- um chloride alone.
  9. Explain findings from a literature review related to the rate of IVAD occlusion from flushing and locking the devices with 0.9% sodium chloride alone.
  10. Identify features of transfusion-associated adverse events (TAAEs).
  11. Apply a TAAE Process algorithm to the care of a patient experiencing a TAAE.

Learning Outcomes

Seventy-five percent of participants will demonstrate knowledge of current issues affecting infusion nursing practice by achieving a minimum score of 70% on the outcomes-based posttest.
Price: $200.00

Credits:

  • ANCC 5.5 CH
  • INCC 10.0 CRNI
  • DC - BON 5.5 CH
  • FL - BON 5.5 CH
  • GA - BON 5.5 CH
  • NM - BON 5.5 CH
  • SC - BON 5.5 CH
  • WV - BOERN 5.5 CH

Lippincott Professional Development is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation. This activity is also provider approved by the California Board of Registered Nursing, Provider Number CEP 11749. Lippincott Professional Development is also an approved provider of continuing nursing education by the District of Columbia Board of Nursing, Florida Board of Nursing, Georgia Board of Nursing, New Mexico Board of Nursing, South Carolina Board of Nursing, and West Virginia Board of Examiners for Registered Professional Nurses, #50-1223.

The Infusion Nurses Certification Corporation (INCC) has approved this CNE activity for 10 CRNI® recertification units.













Test Code: JINNR0922
Published: September 2022; Vol 45, No 5
Expires: 9/5/2025
Required Passing Score: 28/35 (80%)
Authors: Ann Plohal , PhD, RN, ACNS-BC, CRNI, et. al.; Handan Eren , PhD, MSc, BSc, RN, et. al.; Megan Hoffman , MSN, CNS, CMSRN, AOCNS, AGCNS-BC, EBP, et. al.; Nicole C. Lea , MSN, APRN, CPNP, CPHQ